全文获取类型
收费全文 | 1377篇 |
免费 | 145篇 |
国内免费 | 7篇 |
学科分类
医药卫生 | 1529篇 |
出版年
2022年 | 7篇 |
2021年 | 20篇 |
2020年 | 13篇 |
2019年 | 28篇 |
2018年 | 41篇 |
2017年 | 26篇 |
2016年 | 30篇 |
2015年 | 22篇 |
2014年 | 43篇 |
2013年 | 28篇 |
2012年 | 51篇 |
2011年 | 45篇 |
2010年 | 41篇 |
2009年 | 43篇 |
2008年 | 51篇 |
2007年 | 53篇 |
2006年 | 64篇 |
2005年 | 44篇 |
2004年 | 49篇 |
2003年 | 48篇 |
2002年 | 44篇 |
2001年 | 35篇 |
2000年 | 34篇 |
1999年 | 38篇 |
1998年 | 39篇 |
1997年 | 56篇 |
1996年 | 55篇 |
1995年 | 45篇 |
1994年 | 41篇 |
1993年 | 38篇 |
1992年 | 33篇 |
1991年 | 18篇 |
1990年 | 24篇 |
1989年 | 18篇 |
1988年 | 28篇 |
1987年 | 23篇 |
1986年 | 27篇 |
1985年 | 19篇 |
1984年 | 18篇 |
1983年 | 15篇 |
1982年 | 17篇 |
1981年 | 16篇 |
1980年 | 8篇 |
1979年 | 7篇 |
1978年 | 5篇 |
1977年 | 8篇 |
1976年 | 15篇 |
1975年 | 9篇 |
1973年 | 6篇 |
1968年 | 5篇 |
排序方式: 共有1529条查询结果,搜索用时 6 毫秒
81.
Pathologic flow profiles in renal arteries can be found in cardiovascular and renovascular disease. Obstructions of the left hart (aortic stenosis, hypoplastic left heart syndrome, coarctation of the aorta) cause diminished flow with low peak systolic velocities. In renal arteries of infants with leakage of the aortic "Windkessel" (persistent ductus arteriosus, truncus arteriosus communis etc.) a low diastolic amplitude can be found. Significant left-to-right shunts can lead to a diminished or even retrograde diastolic flow. In renal artery stenosis a high velocity jet with spectral broadening can be found in the region of the stenosis. Distal to the stenosis low blood flow velocities can be shown. In renal vein thrombosis the obstruction of the peripheral vessels cause a missing or even negative diastolic flow in the renal arteries, whereas venous blood flow is diminished or even missing. Kidney diseases with swelling of the organ (acute rejection of a transplanted kidney) can cause diminished, missing or even retrograde diastolic flow in the renal arteries dependent on the severity of the edema. These alterations can be used for the early diagnosis of acute rejection which offers the opportunity for early and efficient therapeutic management. 相似文献
82.
M. Delukina Y. Kapelushnik R. Or E. Naparstek S. Slavin A. Nagler 《Medical oncology (Northwood, London, England)》1995,12(2):125-127
The case of a 5 year old male is described who had acute myeloblastic leukaemia (AML M5) and was in third remission when he
underwent an allogeneic T cell depleted bone marrow transplantation (BMT). The bone marrow was from an HLA matched unrelated
donor (MUD) who suffered from chronic idiopathic thrombocytopenic purpura (ITP). In spite of this, the patient had rapid platelet
engraftment post BMT (>50×109 1−1 on day 20). He is now 12 months post-transplantation and has normal platelet counts, without any clinical or laboratory evidence
of ITP. Autoimmune manifestations such as ITP occurring in bone marrow recipients following BMT have been previously reported.
Furthermore, severe and protracted thrombocytopenia is a known complication following MUD transplantation and with its respective
high risk of graftversus host disease (GVHD). In this case, no signs of ITP could be detected in the recipient despite the fact that the donor had
ITP. Our data suggest that in the absence of an alternative choice, a person with ITP should be considered as an appropriate
donor for transplantation. 相似文献
83.
Growth inhibition of prostate cancer xenografts by halofuginone 总被引:3,自引:0,他引:3
BACKGROUND: Halofuginone, an inhibitor of collagen type I synthesis, is an anti-angiogenic agent. Here we evaluated the efficacy of halofuginone to inhibit prostate cancer (PC) xenografts representing various phenotypes of the disease. METHODS: An androgen-dependent (CWR22), an androgen-independent (PC3), and a neuroendocrine (WISH-PC2) PC xenograft were used. Halofuginone was given orally or injected intraperitoneally. Tumor size, collagen alpha1(I) gene expression (in situ hybridization), collagen content (sirius red staining), angiogenesis (immunohistochemistry with factor VIII antibodies), and apoptosis/necrosis (DNA fragmentation) were evaluated. RESULTS: Halofuginone inhibited the growth of all subcutaneously implanted xenografts and of WISH-PC2 when transplanted orthotopically. The effect was dose-dependent (WISH-PC2) and accompanied by decrease in plasma PSA levels (CWR22). In all xenografts, halofuginone inhibited collagen alpha1(I) gene expression, reduced collagen content, and endothelial cell number resulting in an increase in apoptosis/necrosis. CONCLUSIONS: Oral administration of halofuginone slowed the progression of PC xenografts representing a broad range of phenotypes. Halofuginone may become a new modality for PC prevention. 相似文献
84.
The improved performance of modern automobiles often results in higher driving speeds, rendering traffic accidents much more
devastating. Many of our facially injured patients require multidisciplinary and multistage treatment, which is often both
sophisticated and radical. We present a patient with complex facial trauma, discuss his injury characteristics and the multistage
treatment performed, and review the literature. 相似文献
85.
86.
A Shimoni I Hardan N Shem-Tov M Yeshurun R Yerushalmi A Avigdor I Ben-Bassat A Nagler 《Leukemia》2006,20(2):322-328
Allogeneic stem-cell transplantation (SCT) with both myeloablative and reduced-intensity conditioning (RIC) is an effective therapy in AML/MDS. However, the relative merits of each may differ in different settings. To define the role of dose intensity, we analyzed SCT outcomes of 112 consecutive patients with AML/MDS. A total of 45 patients met eligibility criteria for standard myeloablative conditioning and were given intravenous-busulfan (12.8 mg/kg) and cyclophosphamide (ivBuCy). A total of 67 noneligible patients were given RIC with fludarabine and intravenous-busulfan (6.4 mg/kg, FB2, n=41) or a modified myeloablative regimen with fludarabine and myeloablative doses of intravenous-busulfan (12.8 mg/kg, FB4, n=26). The overall survival (OS) at 2 years was 50, 49 and 47% after ivBuCy, FB4 and FB2, respectively (P=NS). Nonrelapse mortality was higher after ivBuCy, 22 vs 8% (P=0.05), but relapse rates were lower. Active disease at SCT was the most significant predictor of reduced survival in multivariable analysis (HR 4.5, P=0.0001). Myeloablative and RIC regimens had similar outcomes when leukemia was in remission at SCT; however, patients with active disease could only be salvaged by myeloablative conditioning. Among the latter, OS was 45% after ivBuCy but no FB2 recipient survived (P=0.02). Patients with active disease, ineligible for standard myeloablation, could tolerate modified myeloablation well; however, long-term outcome cannot be determined yet. 相似文献
87.
Fludarabine-based protocol for haploidentical peripheral blood stem cell transplantation in Hurler syndrome 总被引:7,自引:0,他引:7
Kapelushnik J Mandel H Varadi G Nagler A 《Journal of pediatric hematology/oncology》2000,22(5):433-436
To assess the feasibility of performing a haploidentical peripheral blood stem cell transplantation (PBSCT) in a child with Hurler syndrome after a novel conditioning regimen consisting of fludarabine monophosphate, anti-T-lymphocyte globulin, low-dose busulfan, and single-dose total body irradiation of 750 cGy. A 16-month old boy with Hurler syndrome underwent haploidentical PBSCT from his 3/6 HLA-matched sister. Pretransplant conditioning consisted of fludarabine (30 mg/m2 per day) from day -10 to day -5, busulfan (4 mg/kg per day) on days -7 and -6, rabbit anti-T-lymphocyte globulin (10 mg/kg per day) from day -4 to day -1, and total body irradiation of 750 cGy on day -1. In vitro T-cell depletion was carried out with rat antihuman CDw52 monoclonal antibody (Campath-1G). The fludarabine-based protocol was well-tolerated, with mild toxicity and no major transplant-related complications or graft-versus-host disease. Engraftment was complete and stable. Chimerism was 100% donor origin, as determined by restriction fragment length polymorphism. Cytogenetic and polymerase chain reaction-various number of tandem repeats (PCR-VNTR) analyses of peripheral blood and bone marrow showed 100% reconstitution with female donor cells. The patient underwent the transplant 30 months ago and is in good clinical condition, with normal counts, no signs of graft-versus-host disease, and no infectious episodes; neurologic signs have stabilized. Haploidentical PBSCT, T-cell-depleted by means of Campath-1G, may serve as a therapeutic alternative for patients with Hurler syndrome when a fully matched sibling is not available. 相似文献
88.
Amos Toren Yaron Ilan Reuven Or Joseph Kapelushnik Arnon Nagler 《Medical oncology (Northwood, London, England)》1997,14(3-4):125-129
Antithymocyte globulin (ATG) is traditionally used as a conventional immunosuppression agent in various pathological states including severe aplastic anaemia (SAA), graft versus host disease (GVHD), and for the prevention and treatment of graft rejection and GVHD post bone marrow and liver transplantation. We reviewed the liver functions of 16 haematological patients with no previous liver disorders who received ATG as part of their pre-bone marrow transplantation (BMT) conditioning regimen, and the liver function tests of five SAA patients who received ATG as part of their treatment. Liver functions were evaluated at day — 1 pre-, and days +3 and +10 post-ATG treatment. All patients had normal liver functions before treatment. In the haematological patients, the mean serum lactic dehydrogenase (LDH) levels increased from 408.7 ± 37.7 U/l pre-treatment to 1394.4 ± 488.7 U/l 3 days post-treatment (n = 16;p < 0.029), and then declined to 561.4 ± 61.3 U/l 10 days post-treatment (n = 16;p < 0.043). The mean alanine aminotransferase (ALT) levels increased from 51.9 ± 11.3 U to 184.6 ± 74.6 U (n = 16;p < 0.036), and then declined to 121.9 ± 61.3 U (n = 16; NS). The mean aspartate amino transferase (AST) levels increased from 31.2 ± 5.7 U to 152.0 ± 67.0 U (n = 16;p < 0.44) and then declined to 46.0 ± 14 (n = 16;p < 0.049). The mean r-glutamyltransferase (GTP) levels increased from 93.0 ± 34 to 188.0 ±36 (n = 16;p < 0.02), and were 168.0 ± 37.0 at day +10 (n = 16; NS). The mean bilirubin levels increased from 18.0 ± 1.9μM I-1 to 22.7 ± 2.8 (n = 16); NS), at day +3 and to 31.9 ± 6.9 at day +10 (n = 16; NS). In contrast, no significant changes in liver function tests were demonstrated in the SAA patients treated with ATG. The possible pathophysiologic mechanisms and the clinical implications for liver transplantation are discussed. 相似文献
89.
Immunological and functional protein S, protein C and antithrombin III levels and anticoagulant responses to activated protein C were measured in 24 patients with stroke in childhood. No hereditary deficiencies were found. The protein S levels in healthy controls of younger age did not differ from the adult levels. For optimal screening of protein S deficiency, measurements using functional as well as immunological assays are recommended. Appropriate criteria for the diagnosis of the deficiencies must be carefully applied if unnecessary anxiety and inappropriate treatment of children are to be avoided. 相似文献
90.